Australia markets closed

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.3200+0.0500 (+2.20%)
At close: 3:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 550.46M
Enterprise value 317.21M
Trailing P/E 3.87
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1.31
Price/book (mrq)1.00
Enterprise value/revenue 30.45
Enterprise value/EBITDA 71.26

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-51.16%
S&P500 52-week change 335.11%
52-week high 311.9900
52-week low 32.2300
50-day moving average 32.4215
200-day moving average 33.1397

Share statistics

Avg vol (3-month) 3735.77k
Avg vol (10-day) 3513.33k
Shares outstanding 521.75M
Implied shares outstanding 6N/A
Float 7.08M
% held by insiders 167.46%
% held by institutions 10.23%
Shares short (30 Aug 2021) 461.81k
Short ratio (30 Aug 2021) 40.15
Short % of float (30 Aug 2021) 40.67%
Short % of shares outstanding (30 Aug 2021) 40.28%
Shares short (prior month 29 July 2021) 455.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 24.95%
Operating margin (ttm)34.33%

Management effectiveness

Return on assets (ttm)17.61%
Return on equity (ttm)28.26%

Income statement

Revenue (ttm)38.61M
Revenue per share (ttm)2.40
Quarterly revenue growth (yoy)48.20%
Gross profit (ttm)14.09M
EBITDA 13.7M
Net income avi to common (ttm)9.63M
Diluted EPS (ttm)0.5990
Quarterly earnings growth (yoy)40.90%

Balance sheet

Total cash (mrq)36M
Total cash per share (mrq)1.65
Total debt (mrq)2.75M
Total debt/equity (mrq)5.41
Current ratio (mrq)3.73
Book value per share (mrq)2.33

Cash flow statement

Operating cash flow (ttm)-1.21M
Levered free cash flow (ttm)-645.13k